Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins.
Roshandel D, Klein R, Klein BE, Wolffenbuttel BH, van der Klauw MM, van Vliet-Ostaptchouk JV, Atzmon G, Ben-Avraham D, Crandall JP, Barzilai N, Bull SB, Canty AJ, Hosseini SM, Hiraki LT, Maynard J, Sell DR, Monnier VM, Cleary PA, Braffett BH; DCCT/EDIC Research Group; Paterson AD. Roshandel D, et al. Among authors: cleary pa. Diabetes. 2016 Jul;65(7):2060-71. doi: 10.2337/db15-1484. Epub 2016 Apr 12. Diabetes. 2016. PMID: 27207532 Free PMC article.
A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose.
Paterson AD, Waggott D, Boright AP, Hosseini SM, Shen E, Sylvestre MP, Wong I, Bharaj B, Cleary PA, Lachin JM; MAGIC (Meta-Analyses of Glucose and Insulin-related traits Consortium); Below JE, Nicolae D, Cox NJ, Canty AJ, Sun L, Bull SB; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Paterson AD, et al. Among authors: cleary pa. Diabetes. 2010 Feb;59(2):539-49. doi: 10.2337/db09-0653. Epub 2009 Oct 29. Diabetes. 2010. PMID: 19875614 Free PMC article.
The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.
Monnier VM, Sell DR, Strauch C, Sun W, Lachin JM, Cleary PA, Genuth S; DCCT Research Group. Monnier VM, et al. Among authors: cleary pa. J Diabetes Complications. 2013 Mar-Apr;27(2):141-9. doi: 10.1016/j.jdiacomp.2012.10.004. Epub 2012 Nov 12. J Diabetes Complications. 2013. PMID: 23153673 Free PMC article. Clinical Trial.
Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Cleary PA, Braffett BH, Orchard T, Lyons TJ, Maynard J, Cowie C, Gubitosi-Klug RA, Way J, Anderson K, Barnie A, Villavicencio S; DCCT/EDIC Research Group. Cleary PA, et al. Diabetes Technol Ther. 2013 Jun;15(6):466-74. doi: 10.1089/dia.2012.0316. Diabetes Technol Ther. 2013. PMID: 23882708 Free PMC article. Clinical Trial.
GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence.
Eny KM, Lutgers HL, Maynard J, Klein BE, Lee KE, Atzmon G, Monnier VM, van Vliet-Ostaptchouk JV, Graaff R, van der Harst P, Snieder H, van der Klauw MM, Sell DR, Hosseini SM, Cleary PA, Braffett BH, Orchard TJ, Lyons TJ, Howard K, Klein R, Crandall JP, Barzilai N, Milman S, Ben-Avraham D; LifeLines Cohort Study Group; DCCT/EDIC Research Group; Wolffenbuttel BH, Paterson AD. Eny KM, et al. Among authors: cleary pa. Diabetologia. 2014 Aug;57(8):1623-34. doi: 10.1007/s00125-014-3286-9. Epub 2014 Jun 17. Diabetologia. 2014. PMID: 24934506 Free PMC article.
Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes.
Eny KM, Orchard TJ, Miller RG, Maynard J, Grant DM, Costacou T, Cleary PA, Braffett BH, Paterson AD; DCCT/EDIC Research Group. Eny KM, et al. Among authors: cleary pa. Diabetes Technol Ther. 2015 Oct;17(10):726-34. doi: 10.1089/dia.2015.0017. Epub 2015 Jul 20. Diabetes Technol Ther. 2015. PMID: 26192006 Free PMC article. Clinical Trial.
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM; DCCT Skin Collagen Ancillary Study Group. Genuth S, et al. Diabetes. 2005 Nov;54(11):3103-11. doi: 10.2337/diabetes.54.11.3103. Diabetes. 2005. PMID: 16249432 Free PMC article.
Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S. Monnier VM, et al. Among authors: cleary pa. Diabetes. 1999 Apr;48(4):870-80. doi: 10.2337/diabetes.48.4.870. Diabetes. 1999. PMID: 10102706 Free PMC article.
The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.
Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Paterson AD, et al. Among authors: cleary pa. Diabetes Care. 2007 Aug;30(8):2107-12. doi: 10.2337/dc06-1441. Epub 2007 Apr 27. Diabetes Care. 2007. PMID: 17468351 Free PMC article.
171 results